KCIA
ABBV icon

Kingsbury Capital Investment Advisors’s AbbVie ABBV Stock Holding History

Kingsbury Capital Investment Advisors’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		$343K Sell
2,553
-32
-1% -$4.59K 0.52% 42
2022
Q2 		$396K Sell
2,585
-623
-19% -$95.2K 0.55% 45
2022
Q1 		$520K Buy
+3,208
New +$466K 0.57% 37

Other funds holding ABBV

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Kingsbury Capital Investment Advisors's ABBV Position: Q3 2022 in Review

Kingsbury Capital Investment Advisors reduced its AbbVie (ABBV) stake by 1.2% in Q3 2022, selling an estimated $4.59K and leaving 2,553 shares worth $343K. The position accounts for 0.52% of the portfolio, ranked #42.

Kingsbury Capital Investment Advisors first reported a position in ABBV in Q1 2022 and has held it in 3 quarters since. The position peaked at $520K in Q1 2022. 2,969 funds tracked by Wall St. Rank hold ABBV as of Q3 2022.

  • Kingsbury Capital Investment Advisors held 2,553 shares of AbbVie worth $343K as of Q3 2022.
  • Kingsbury Capital Investment Advisors sold 32 AbbVie shares in Q3 2022, an estimated $4.59K.
  • AbbVie made up 0.52% of Kingsbury Capital Investment Advisors's portfolio in Q3 2022, its #42 holding.
  • Kingsbury Capital Investment Advisors first reported a position in AbbVie in Q1 2022 and has held it in 3 quarters since.
  • Kingsbury Capital Investment Advisors's AbbVie position peaked at $520K in Q1 2022.
  • 2,969 funds tracked by Wall St. Rank held AbbVie as of Q3 2022.

Based on Kingsbury Capital Investment Advisors's 13F filing for Q3 2022, filed 10 Nov 2022.